Minovia Therapeutics Ltd. (“Minovia” or the “Company”), a clinical-stage biotechnology company developing novel therapies to treat mitochondrial diseases and combat age-related decline, announces that ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the presentation of additional data ...